DIALYSIS CLINIC INC
1633 CHURCH STREET NO 500, NASHVILLE, TN 37203 www.dciinc.org

Total Revenue
$739,130,845
Total Expenses
$731,344,904
Net Assets
$612,817,876

Organizations Filed Purposes: THE PRIMARY RESPONSIBILITY OF DIALYSIS CLINIC INC. (DCI) IS TO PERCEIVE, INITIATE, AND PROVIDE COMPREHENSIVE PATIENT CARE. WE SERVE SOCIETY BY PROVIDING CARE FOR PATIENTS WITH CHRONIC KIDNEY DISEASE.

TO INITIATE AND PROVIDE COMPREHENSIVE CARE FOR PATIENTS WITH END-STAGE RENAL DISEASE.

THE DIALYSIS DIVISION IS THE PRINCIPAL ACTIVITY OF OUR COMPANY AND IS PRIMARILY INVOLVED WITH PROVIDING KIDNEY DIALYSIS AND RELATED SERVICES FOR INSURED AND UNINSURED PATIENTS. RENAL DIALYSIS IS NOT AN ELECTIVE MEDICAL PROCEDURE, BUT A LIFE-SUSTAINING TREATMENT FOR PEOPLE LIVING WITH KIDNEY FAILURE. PROVIDING THESE MEDICALLY-NECESSARY TREATMENTS FURTHERS OUR EXEMPT PURPOSE OF PROVIDING QUALITY OUTPATIENT CARE FOR ALL PATIENTS WITH END-STAGE RENAL DISEASE, WHICH INCLUDES THE APPLICATION OF COMPANY RESOURCES FOR SCIENTIFIC AND EDUCATIONAL PURPOSES FOR THE PREVENTION, EARLY DETECTION, AND TREATMENT OF RENAL DISEASE. DURING FYE 2019, 2,193,987 DIALYSIS PROCEDURES WERE PERFORMED. A SIGNIFICANT PORTION OF OUR DIALYSIS CHARGES ARE COVERED BY MEDICARE AND STATE MEDICAID PROGRAMS, WHILE THE REMAINING COSTS ARE PAID BY THIRD PARTY INSURERS, AND CHARITY CARE. CHARITY CARE IS PROVIDED TO PATIENTS WHO MEET CERTAIN CRITERIA UNDER OUR CHARITY CARE POLICY WITHOUT CHARGE OR AT AMOUNTS LESS THAN OUR ESTABLISHED RATES.

THE LAB DIVISION PROVIDES SPECIALIZED LABORATORY TESTING AND DIAGNOSTIC PROCEDURES FOR DIALYSIS FACILITIES AND PATIENTS WITH KIDNEY DISEASE AND RENAL FAILURE. A VARIETY OF LABORATORY TESTS TO ANALYZE DIFFUSED TOXINS FROM THE BLOOD ARE NECESSARY TO MONITOR THE CLINICAL COURSE OF PATIENTS AND THE OVERALL EFFECTIVENESS OF RENAL DIALYSIS. THESE TESTS ARE NECESSARY IN THE TREATMENT OF RENAL DISEASE, AND FURTHERS OUR EXEMPT PURPOSE OF PROVIDING QUALITY CARE FOR PATIENTS WITH CHRONIC RENAL DISEASE BY CONTINUALLY IMPROVING OUR PROCESSES IN MEASURING LEVELS OF KIDNEY FUNCTION TO PRODUCE OPTIMAL PATIENT OUTCOMES. FOR FYE 09/30/2019, 897,934 PATIENT TESTS WERE PERFORMED.

THE SUPPLY AND PHARMACY DIVISION PROVIDES MEDICAL SUPPLIES, INCLUDING BUT NOT LIMITED TO NUTRITIONAL SUPPLEMENTS, DRUGS, AND HOME DIALYSIS SUPPLIES FOR DCI FACILITIES AND PROVIDES PRESCRIPTION MEDICATIONS FOR DCI EMPLOYEES.

Executives Listed on Filing

Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing

NameTitleHours Per WeekTotal Salary
William E WoodPRESIDENT40$1,092,285
Amit NahataPHYSICIAN40$595,088
Jessie GanjooPHYSICIAN40$581,148
James E AttrillVICE PRESIDENT40$512,523
Rose SmithSENIOR OPERATIONS DIRECTOR40$496,210
Mostafa AmrPHYSICIAN40$489,026
Margaret WilliamsDIRECTOR OF COMPLIANCE40$470,140
Doug JohnsonVICE CHAIRMAN40$448,890
Stuart RedpathCHIEF OPERATIONS OFFICER40$434,199
Mary HobeikaCHIEF STRATEGY OFFICER40$197,241
Joe SwearingenASSISTANT TREASURER40$193,626
Donovan SchultzCHIEF FINANCIAL OFFICER40$167,343
James PerryDIRECTOR20$37,103
Ken JohnsonDIRECTOR2$0
H Keith JohnsonCHAIRMAN32$0

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202022309349302282_public.xml